| Effects of Diazepam on RNS Detections (NCT05273398) | University of Cincinnati | 2022-03-01 |
| Thermocoagulation in Drug Resistant Focal Epilepsy (NCT05248269) | State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | 2022-02-07 |
| Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies (NCT05015868) | IRCCS Eugenio Medea | 2021-07-15 |
| Transcranial Direct Current to Treat Epilepsy at Home (NCT04309812) | Stanford University | 2021-05-26 |
| Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (NCT03689114) | Mario Negri Institute for Pharmacological Research | 2021-05-10 |
| Treating Postictal Symptoms Using Ibuprofen and Nifedipine (NCT03949478) | University of Calgary | 2021-02-01 |
| Novel Network Analysis of Intracranial Stereoelectroencephalography (NCT03916848) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2019-06-16 |
| Added Value of Automated Electrical Source Localization (EPILOG PreOp®) to Presurgical Evaluation of Refractory Epilepsy (NCT03882151) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-01-15 |
| Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study (NCT03446664) | LivaNova | 2018-02-27 |
| Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study (NCT03054961) | Medical College of Wisconsin | 2017-02-10 |
| Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept (NCT02635633) | University Hospital, Ghent | 2015-08-01 |
| Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy (NCT03200769) | University Hospital, Lille | 2014-07-21 |
| Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS) (NCT01745952) | Universitaire Ziekenhuizen KU Leuven | 2012-11-01 |
| Brain P-gp and Inflammation in People With Epilepsy (NCT01663545) | National Institute of Neurological Disorders and Stroke (NINDS) | 2012-07-31 |
| Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan) (NCT01441401) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-12-01 |
| Once-A-Day Pregabalin For Partial Seizures (NCT01262677) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-17 |
| Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug (NCT01098162) | UCB Pharma GmbH | 2010-03-01 |
| Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients (NCT00918047) | Supernus Pharmaceuticals, Inc. | 2009-06-01 |
| Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (NCT00771927) | UCB Pharma | 2008-10-01 |
| A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures (NCT00620555) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-05-01 |
| A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures (NCT00422110) | UCB Pharma | 2008-05-01 |
| Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures (NCT00537940) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-02-01 |
| A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures (NCT00603473) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-01-01 |
| Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures (NCT00524030) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-09-01 |
| Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures (NCT00448916) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-05-01 |
| Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures (NCT00437281) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-04-01 |
| An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. (NCT00991757) | SK Life Science, Inc. | 2007-02-01 |
| Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo (NCT00351611) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-07-26 |
| Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. (NCT00319501) | Pfizer | 2006-01-01 |
| A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy (NCT00266604) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-12-01 |
| A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures (NCT00280696) | UCB Japan Co. Ltd. | 2005-11-01 |
| An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy (NCT00210522) | SK Life Science, Inc. | 2005-05-01 |
| Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures (NCT00215215) | Cyberonics, Inc. | 2005-02-01 |
| Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures (NCT00151879) | UCB Pharma | 2005-02-01 |
| An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy (NCT00210652) | SK Life Science, Inc. | 2004-07-01 |
| Pilot Trial of a Behavioral Treatment for Epilepsy (NCT00212745) | Oregon Health and Science University | 2004-02-01 |
| MRI in Autosomal Dominant Partial Epilepsy With Auditory Features (NCT00072813) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-11-10 |
| A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures (NCT00643136) | Pfizer | 2002-11-01 |
| Pediatric Epilepsy Study (NCT00050934) | Novartis Pharmaceuticals | 2002-06-01 |
| Pregabalin Open-Label Extension Trial in Patients With Partial Seizures (NCT00143143) | Pfizer | 2001-09-01 |
| A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy (NCT00231556) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1999-07-01 |
| Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients (NCT00236886) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1998-05-01 |
| A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure (NCT00230698) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-11-01 |
| A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy (NCT00236743) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1994-06-01 |
| A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. (NCT00236847) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-12-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. (NCT00236873) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-10-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures (NCT00236860) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-05-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. (NCT00236691) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-07-01 |
| A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy (NCT00236730) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-06-01 |